electroCore (ECOR) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -232.83% |
| Dec 31, 2025 | -59.27% |
| Sep 30, 2025 | -196.41% |
| Jun 30, 2025 | -74.50% |
| Mar 31, 2025 | -42.14% |
| Dec 31, 2024 | -20.21% |
| Sep 30, 2024 | -17.58% |
| Jun 30, 2024 | 155.16% |
| Mar 31, 2024 | -39.59% |
| Dec 31, 2023 | -32.59% |
| Sep 30, 2023 | 56.29% |
| Jun 30, 2023 | -40.37% |
| Mar 31, 2023 | -30.66% |
| Dec 31, 2022 | -23.05% |
| Sep 30, 2022 | -18.29% |
| Jun 30, 2022 | -14.59% |
| Mar 31, 2022 | -13.18% |
| Dec 31, 2021 | -10.87% |
| Sep 30, 2021 | 67.03% |
| Jun 30, 2021 | -7.69% |
| Mar 31, 2021 | 12.79% |
| Dec 31, 2020 | -18.18% |
| Sep 30, 2020 | 34.13% |
| Jun 30, 2020 | 21.48% |
| Mar 31, 2020 | -28.77% |
| Dec 31, 2019 | -22.91% |
| Sep 30, 2019 | -22.66% |
| Jun 30, 2019 | -21.47% |
| Mar 31, 2019 | -19.67% |
| Dec 31, 2018 | -17.67% |
| Sep 30, 2018 | -13.51% |
| Jun 30, 2018 | 194.05% |
| Mar 31, 2018 | -10.47% |